RS-23581

N/A

Report date: 2024/12/06 10:45:00

Base Information

Drug NameRS-23581
Drug Alias NameRS-23581
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteogenesis stimulantsParathyroid hormone receptor agonists
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsOsteoporosis, Postmenopausal

Other Information

ATC CodeN/A
Related LinksN/A